Repros Therapeutics Inc. (NASDAQ: RPRX) is on The StockGuru Leader Board today.  The stock is up as much as 24.88% on Thursday.

Volume traded – so far – as this release was issued intraday:  1,163,345

Join in on the Discussion about RPRXhttp://members.stockguru.com/stocks/rprx/

About the Company:

Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders. Its primary product candidate includes Androxal, an orally active proprietary small molecule compound that has completed Phase IIb study in men, which normalizes testicular function for the treatment of low testosterone due to secondary hypogonadism; and has completed a Phase II clinical trial for the treatment of hypogonadal men with type 2 diabetes. The company also offers Proellex that acts as a selective blocker of the progesterone receptor in women for the treatment of symptoms associated with uterine fibroids and endometriosis. In addition, it provides phentolamine-based product candidates, including VASOMAX for the treatment of male erectile dysfunction. The company was formerly known as Zonagen, Inc. and changed its name to Repros Therapeutics Inc. in May 2006. Repros Therapeutics Inc. was founded in 1987 and is based in The Woodlands, Texas.

About the StockGuru Leader Board:

We watch for stocks moving up and creating a positive momentum in the market.  We are not compensated for coverage.

Feel free to suggest a stock for coverage if you see it breaking out.  Contact: [email protected].

StockGuru.com
StockGuruCanada.com
Shareholdervision.com
BoldStocks.com
IR Affiliates – IRIR.co
StoneBridge Web & SEO – StonebridgeIQ.com

All content on StockGuru.com is original content – with the exception of client news releases. All content is (C) Copyright 2002 to 2012 StockGuru. No content may be used in whole or in part without the express written consent of our Publisher. We encourage web sites interested in our content to offer a reciprocal exchange agreement in exchange for use of some of our content. We do not offer advance approval, but contact our Publisher if you have an interest in repropagating our content. Contact as at: [email protected] or (469) 252-3030. Mailing address: 1601 Berwick Drive; McKinney, Texas 75070